Birich Technologies Overview
- Founded
- 2011
- Status
- Out of Business
- Latest Deal Type
- Out of Business
Birich Technologies General Information
Description
Developer of gene-silencing technology designed to detect diseases. The company's gene-silencing technology offers a proprietary protein delivery technology for RNAI, enabling doctors to detect and treat gene related diseases.
Contact Information
Website
www.birichtech.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Primary Office
- 301 West Preston Street
- Room 801
- Baltimore, MD 21201
- United States
Birich Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-Nov-2016 | 00000 | Completed | Out of Business | ||
| 2. Seed Round | 26-Feb-2014 | 00000 | 00000 | Completed | Startup | |
| 1. Accelerator/Incubator | 20-Feb-2013 | $149K | $149K | Completed | Startup |
Birich Technologies Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Vivek Advani | Acting Chief Technology Officer | ||
| Chanda Arya Ph.D | Co-Founder & President |